BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 18280593)

  • 1. Giant cell myocarditis triggered by a parvovirus B19 infection.
    Dennert R; Schalla S; Suylen RJ; Eurlings L; Heymans S
    Int J Cardiol; 2009 May; 134(1):115-6. PubMed ID: 18280593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fulminant myocarditis associated with parvovirus B19 infection in a child.
    Dina J; Vabret A; Rambaud C; Checoury A; Gouarin S; Petitjean J; Freymuth F
    J Clin Virol; 2008 May; 42(1):70-1. PubMed ID: 18313977
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease.
    Bültmann BD; Klingel K; Sotlar K; Bock CT; Baba HA; Sauter M; Kandolf R
    Hum Pathol; 2003 Jan; 34(1):92-5. PubMed ID: 12605372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active, fulminant, lethal myocarditis associated with parvovirus B19 infection in an infant.
    Papadogiannakis N; Tolfvenstam T; Fischler B; Norbeck O; Broliden K
    Clin Infect Dis; 2002 Nov; 35(9):1027-31. PubMed ID: 12384834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulminant parvovirus B19-associated pancarditis with haemophagocytic lympho-histiocytosis in an immunocompetent adult.
    Bal A; Mishra B; Singh N; Das A; Jindal SK
    APMIS; 2009 Oct; 117(10):773-7. PubMed ID: 19775347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal course of parvovirus B19-associated myocarditis in a female liver transplant recipient.
    Jonetzko P; Graziadei I; Nachbaur K; Vogel W; Pankuweit S; Zwick R; Pachinger O; Poelzl G
    Liver Transpl; 2005 Apr; 11(4):463-6. PubMed ID: 15776413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal parvovirus B19 myocarditis in an 8-year-old boy.
    Dettmeyer R; Kandolf R; Baasner A; Banaschak S; Eis-Hübinger AM; Madea B
    J Forensic Sci; 2003 Jan; 48(1):183-6. PubMed ID: 12570225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parvovirus B19 is a bystander in adult myocarditis.
    Koepsell SA; Anderson DR; Radio SJ
    Cardiovasc Pathol; 2012; 21(6):476-81. PubMed ID: 22425629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parvovirus-B19-associated fulminant myocarditis successfully treated with immunosuppressive and antiviral therapy.
    Dennert R; Velthuis S; Westermann D; Donker D; Schalla S; van Suylen RJ; Heymans S
    Antivir Ther; 2010; 15(4):681-5. PubMed ID: 20587861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.
    Mahrholdt H; Wagner A; Deluigi CC; Kispert E; Hager S; Meinhardt G; Vogelsberg H; Fritz P; Dippon J; Bock CT; Klingel K; Kandolf R; Sechtem U
    Circulation; 2006 Oct; 114(15):1581-90. PubMed ID: 17015795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and quantity of the parvovirus B19 genome in endomyocardial biopsies from patients with suspected myocarditis or idiopathic left ventricular dysfunction.
    Klein RM; Jiang H; Niederacher D; Adams O; Du M; Horlitz M; Schley P; Marx R; Lankisch MR; Brehm MU; Strauer BE; Gabbert HE; Scheffold T; Gülker H
    Z Kardiol; 2004 Apr; 93(4):300-9. PubMed ID: 15085375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal parvovirus myocarditis in a 5-year-old girl.
    Murry CE; Jerome KR; Reichenbach DD
    Hum Pathol; 2001 Mar; 32(3):342-5. PubMed ID: 11274646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal parvovirus B19 myocarditis in children and possible dysimmune mechanism.
    Koehl B; Oualha M; Lesage F; Rambaud C; Canioni D; Hubert P; Leruez-Ville M
    Pediatr Infect Dis J; 2012 Apr; 31(4):418-21. PubMed ID: 22173134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Virus etiology of inflammatory cardiomyopathy].
    Kandolf R
    Dtsch Med Wochenschr; 2004 Oct; 129(41):2187-92. PubMed ID: 15457399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and aetiological diagnosis of inflammatory myocardial diseases with a special focus on parvovirus B19.
    Pankuweit S; Ruppert V; Eckhardt H; Strache D; Maisch B
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):344-7. PubMed ID: 16316398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac troponin I release in non-ischemic reversible myocardial injury from parvovirus B19 myocarditis.
    Baig MA; Ali S; Khan MU; Rasheed J; Qadir A; Vasavada BC; Khan IA
    Int J Cardiol; 2006 Nov; 113(3):E109-10. PubMed ID: 17010458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human parvovirus B19: a new emerging pathogen of inflammatory cardiomyopathy.
    Bock CT; Klingel K; Aberle S; Duechting A; Lupescu A; Lang F; Kandolf R
    J Vet Med B Infect Dis Vet Public Health; 2005; 52(7-8):340-3. PubMed ID: 16316397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Childhood myocarditis and parvovirus B19 genotypes.
    Dina J; Villedieu F; Labombarda F; Freymuth F; de la Gastine G; Jokic M; Vabret A
    J Clin Virol; 2011 Jan; 50(1):61-4. PubMed ID: 20952249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human parvovirus B19-associated myocarditis.
    Bock CT; Klingel K; Kandolf R
    N Engl J Med; 2010 Apr; 362(13):1248-9. PubMed ID: 20357294
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult.
    Lamparter S; Schoppet M; Pankuweit S; Maisch B
    Hum Pathol; 2003 Jul; 34(7):725-8. PubMed ID: 12874772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.